BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Business

  Duke University Medical Center Chooses Immucor’s Galileo

  February 9, 2006

   · 

  2 min read
• Business

  The Medicines Company To Announce Fourth Quarter And Full Year 2005 Financial Results On Wednesday, February 15, 2006

  February 9, 2006

   · 

  1 min read
• Business

  Dynatronics Announces Second Quarter Results

  February 9, 2006

   · 

  4 min read
• Oncolytics Biotech Inc. To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference

  February 9, 2006

   · 

  2 min read
• Pharm Country

  NovaDel Pharma To Present At Biotechnology Industry Organization (BIO) CEO And Investor Conference

  February 9, 2006

   · 

  1 min read
• Drug Development

  The Immune Response Corporation, Inc. Announces New Business Strategy; Emphasizes Focus On Promising MS Treatment And Second Generation HIV Therapy

  February 9, 2006

   · 

  1 min read
• Drug Development

  Panacos Pharmaceuticals Inc. Presents Data At 13th Conference On Retroviruses And Opportunistic Infections

  February 9, 2006

   · 

  1 min read
• Pharm Country

  Nymox Pharmaceutical’s Alzheimer Drug Programs Generate Several Novel Product Developments

  February 9, 2006

   · 

  1 min read
• Business

  RheoGene, Inc. Grants Ichor Medical Systems, Inc. A Commercial License To Develop A Regulated Gene Therapy For Multiple Sclerosis Using The RheoSwitch® Therapeutic System

  February 9, 2006

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. Announces Interim Results From Phase II Study Of MK-0518, An Investigational Oral HIV Integrase Inhibitor

  February 9, 2006

   · 

  1 min read